Literature DB >> 27197806

Quantification of liver proton-density fat fraction in 7.1T preclinical MR systems: Impact of the fitting technique.

Christoph Mahlke1, Diego Hernando2, Christina Jahn1, Antonio Cigliano3, Till Ittermann4, Anne Mössler5, Marie-Luise Kromrey1, Grazyna Domaska6, Scott B Reeder2,7, Jens-Peter Kühn1.   

Abstract

PURPOSE: To investigate the feasibility of estimating the proton-density fat fraction (PDFF) using a 7.1T magnetic resonance imaging (MRI) system and to compare the accuracy of liver fat quantification using different fitting approaches.
MATERIALS AND METHODS: Fourteen leptin-deficient ob/ob mice and eight intact controls were examined in a 7.1T animal scanner using a 3D six-echo chemical shift-encoded pulse sequence. Confounder-corrected PDFF was calculated using magnitude (magnitude data alone) and combined fitting (complex and magnitude data). Differences between fitting techniques were compared using Bland-Altman analysis. In addition, PDFFs derived with both reconstructions were correlated with histopathological fat content and triglyceride mass fraction using linear regression analysis.
RESULTS: The PDFFs determined with the use of both reconstructions correlated very strongly (r = 0.91). However, small mean bias between reconstructions demonstrated divergent results (3.9%; confidence interval [CI] 2.7-5.1%). For both reconstructions, there was linear correlation with histopathology (combined fitting: r = 0.61; magnitude fitting: r = 0.64) and triglyceride content (combined fitting: r = 0.79; magnitude fitting: r = 0.70).
CONCLUSION: Liver fat quantification using the PDFF derived from MRI performed at 7.1T is feasible. PDFF has strong correlations with histopathologically determined fat and with triglyceride content. However, small differences between PDFF reconstruction techniques may impair the robustness and reliability of the biomarker at 7.1T. J. Magn. Reson. Imaging 2016;44:1425-1431.
© 2016 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  chemical shift imaging; liver fat; proton-density fat fraction; ultra-high-field MRI

Mesh:

Substances:

Year:  2016        PMID: 27197806      PMCID: PMC5116293          DOI: 10.1002/jmri.25319

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  27 in total

1.  Relaxation effects in the quantification of fat using gradient echo imaging.

Authors:  Mark Bydder; Takeshi Yokoo; Gavin Hamilton; Michael S Middleton; Alyssa D Chavez; Jeffrey B Schwimmer; Joel E Lavine; Claude B Sirlin
Journal:  Magn Reson Imaging       Date:  2008-02-21       Impact factor: 2.546

2.  Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise.

Authors:  Chia-Ying Liu; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Magn Reson Med       Date:  2007-08       Impact factor: 4.668

3.  Addressing phase errors in fat-water imaging using a mixed magnitude/complex fitting method.

Authors:  D Hernando; C D G Hines; H Yu; S B Reeder
Journal:  Magn Reson Med       Date:  2011-06-28       Impact factor: 4.668

4.  Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction.

Authors:  Huanzhou Yu; Ann Shimakawa; Catherine D G Hines; Charles A McKenzie; Gavin Hamilton; Claude B Sirlin; Jean H Brittain; Scott B Reeder
Journal:  Magn Reson Med       Date:  2011-02-24       Impact factor: 4.668

5.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

6.  Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.

Authors:  Peter Bannas; Harald Kramer; Diego Hernando; Rashmi Agni; Ashley M Cunningham; Rakesh Mandal; Utaroh Motosugi; Samir D Sharma; Alejandro Munoz del Rio; Luis Fernandez; Scott B Reeder
Journal:  Hepatology       Date:  2015-09-28       Impact factor: 17.425

7.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Chisato Nagata; Jun Takeda; Hiroshi Sarui; Yutaka Kawahito; Naohisa Yoshida; Atsushi Suetsugu; Takahiro Kato; Junichi Okuda; Kazunori Ida; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

Review 8.  Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.

Authors:  Johannes Weiß; Monika Rau; Andreas Geier
Journal:  Dtsch Arztebl Int       Date:  2014-06-27       Impact factor: 5.594

9.  Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.

Authors:  Giovanni Targher; Filippo Valbusa; Stafano Bonapace; Lorenzo Bertolini; Luciano Zenari; Isabella Pichiri; Alessandro Mantovani; Giacomo Zoppini; Enzo Bonora; Enrico Barbieri; Christopher D Byrne
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-01-21       Impact factor: 4.222

10.  Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice.

Authors:  Catherine D G Hines; Huanzhou Yu; Ann Shimakawa; Charles A McKenzie; Thomas F Warner; Jean H Brittain; Scott B Reeder
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.